Literature DB >> 19029823

E2F3 plays an essential role in cardiac development and function.

Jennifer C King1, Ivan P G Moskowitz, Patrick G Burgon, Ferhaan Ahmad, James R Stone, Jonathan G Seidman, Jacqueline A Lees.   

Abstract

The E2F transcription factors are key downstream targets of the retinoblastoma protein tumor suppressor. They are known to regulate the expression of genes that control fundamental biological processes including cellular proliferation, apoptosis and differentiation. However, considerable questions remain about the precise roles of the individual E2F family members. This study shows that E2F3 is essential for normal cardiac development. E2F3-loss impairs the proliferative capacity of the embryonic myocardium and most E2f3(-/-) mice die in utero or perinatally with hypoplastic ventricular walls and/or severe atrial and ventricular septal defects. A small fraction of the E2f3(-/-) neonates have hearts that appear grossly normal and they initially survive. However, these animals display ultrastructural defects in the cardiac muscle and ultimately die as a result of congestive heart failure. These data demonstrate a clear role for E2F3 in myocardial and cardiac function during both development and adulthood.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19029823      PMCID: PMC2723769          DOI: 10.4161/cc.7.23.7240

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  44 in total

1.  Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression.

Authors:  Y Takahashi; J B Rayman; B D Dynlacht
Journal:  Genes Dev       Date:  2000-04-01       Impact factor: 11.361

2.  Identification of a novel E2F3 product suggests a mechanism for determining specificity of repression by Rb proteins.

Authors:  G Leone; F Nuckolls; S Ishida; M Adams; R Sears; L Jakoi; A Miron; J R Nevins
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

3.  Complex transcriptional regulatory mechanisms control expression of the E2F3 locus.

Authors:  M R Adams; R Sears; F Nuckolls; G Leone; J R Nevins
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

Review 4.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

5.  PPAR gamma is required for placental, cardiac, and adipose tissue development.

Authors:  Y Barak; M C Nelson; E S Ong; Y Z Jones; P Ruiz-Lozano; K R Chien; A Koder; R M Evans
Journal:  Mol Cell       Date:  1999-10       Impact factor: 17.970

6.  Identification of E2F-3B, an alternative form of E2F-3 lacking a conserved N-terminal region.

Authors:  Y He; M K Armanious; M J Thomas; W D Cress
Journal:  Oncogene       Date:  2000-07-13       Impact factor: 9.867

Review 7.  E2F-associated chromatin modifiers and cell cycle control.

Authors:  Alexandre Blais; Brian D Dynlacht
Journal:  Curr Opin Cell Biol       Date:  2007-11-19       Impact factor: 8.382

8.  E2f3 is critical for normal cellular proliferation.

Authors:  P O Humbert; R Verona; J M Trimarchi; C Rogers; S Dandapani; J A Lees
Journal:  Genes Dev       Date:  2000-03-15       Impact factor: 11.361

Review 9.  Genetic dissection of cardiac growth control pathways.

Authors:  W R MacLellan; M D Schneider
Journal:  Annu Rev Physiol       Date:  2000       Impact factor: 19.318

10.  Mouse development with a single E2F activator.

Authors:  Shih-Yin Tsai; Rene Opavsky; Nidhi Sharma; Lizhao Wu; Shan Naidu; Eric Nolan; Enrique Feria-Arias; Cynthia Timmers; Jana Opavska; Alain de Bruin; Jean-Leon Chong; Prashant Trikha; Soledad A Fernandez; Paul Stromberg; Thomas J Rosol; Gustavo Leone
Journal:  Nature       Date:  2008-06-25       Impact factor: 49.962

View more
  13 in total

1.  Tissue-specific targeting of cell fate regulatory genes by E2f factors.

Authors:  L M Julian; Y Liu; C A Pakenham; D Dugal-Tessier; V Ruzhynsky; S Bae; S-Y Tsai; G Leone; R S Slack; A Blais
Journal:  Cell Death Differ       Date:  2015-04-24       Impact factor: 15.828

2.  Phenotypic variability of TTR Val122Ile mutation: a Caucasian patient with axonal neuropathy and normal heart.

Authors:  Claudia Stancanelli; Luca Gentile; Gianluca Di Bella; Fabio Minutoli; Massimo Russo; Giuseppe Vita; Anna Mazzeo
Journal:  Neurol Sci       Date:  2016-11-12       Impact factor: 3.307

3.  MiR-15 family regulates postnatal mitotic arrest of cardiomyocytes.

Authors:  Enzo R Porrello; Brett A Johnson; Arin B Aurora; Emma Simpson; Young-Jae Nam; Scot J Matkovich; Gerald W Dorn; Eva van Rooij; Eric N Olson
Journal:  Circ Res       Date:  2011-07-21       Impact factor: 17.367

4.  Wt1 transcription factor impairs cardiomyocyte specification and drives a phenotypic switch from myocardium to epicardium.

Authors:  Ines J Marques; Alexander Ernst; Prateek Arora; Andrej Vianin; Tanja Hetke; Andrés Sanz-Morejón; Uta Naumann; Adolfo Odriozola; Xavier Langa; Laura Andrés-Delgado; Benoît Zuber; Carlos Torroja; Marco Osterwalder; Filipa C Simões; Christoph Englert; Nadia Mercader
Journal:  Development       Date:  2022-03-25       Impact factor: 6.868

5.  E2F6 Impairs Glycolysis and Activates BDH1 Expression Prior to Dilated Cardiomyopathy.

Authors:  Jennifer L Major; Aaraf Dewan; Maysoon Salih; John J Leddy; Balwant S Tuana
Journal:  PLoS One       Date:  2017-01-13       Impact factor: 3.240

6.  ce-Subpathway: Identification of ceRNA-mediated subpathways via joint power of ceRNAs and pathway topologies.

Authors:  Chenchen Feng; Chao Song; Ziyu Ning; Bo Ai; Qiuyu Wang; Yong Xu; Meng Li; Xuefeng Bai; Jianmei Zhao; Yuejuan Liu; Xuecang Li; Jian Zhang; Chunquan Li
Journal:  J Cell Mol Med       Date:  2018-11-12       Impact factor: 5.310

7.  Resveratrol Attenuates High Glucose-Induced Vascular Endothelial Cell Injury by Activating the E2F3 Pathway.

Authors:  Xiaolian Ding; Wei Yao; Jie Zhu; Kaida Mu; Jing Zhang; Jin-An Zhang
Journal:  Biomed Res Int       Date:  2020-04-28       Impact factor: 3.411

8.  Determination of the physiological and pathological roles of E2F3 in adult tissues.

Authors:  Ivonne Gamper; Deborah L Burkhart; Megan J Bywater; Daniel Garcia; Catherine H Wilson; Peter A Kreuzaler; Mark J Arends; Yao-Wu Zheng; Alessandra Perfetto; Trevor D Littlewood; Gerard I Evan
Journal:  Sci Rep       Date:  2017-08-30       Impact factor: 4.379

9.  Identification of transcription factors MYC and C/EBPβ mediated regulatory networks in heart failure based on gene expression omnibus datasets.

Authors:  Haiwei Wang; Xinrui Wang; Liangpu Xu; Hua Cao
Journal:  BMC Cardiovasc Disord       Date:  2020-05-27       Impact factor: 2.298

10.  LncRNA 2310043L19Rik inhibits differentiation and promotes proliferation of myoblast by sponging miR-125a-5p.

Authors:  Rongyang Li; Bojiang Li; Ming Shen; Yan Cao; Xuan Zhang; Weijian Li; Jingli Tao; Wangjun Wu; Honglin Liu
Journal:  Aging (Albany NY)       Date:  2020-03-31       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.